Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
34
Number of overlapping holdings
17.7%
% of IBB's 212 holdings also in GNOM
82.9%
% of GNOM's 41 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 3.2% | 3.2% | 3.2% |
 |
BIONTECH SE SPONSORED ADR | 2.5% | 4.1% | 2.5% |
|
ILLUMINA INC | 2.3% | 3.8% | 2.3% |
|
GILEAD SCIENCES INC | 9.9% | 2.0% | 2.0% |
|
NATERA INC | 2.0% | 5.4% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to GNOM
|
GILEAD SCIENCES INC | 7.9% |
|
AMGEN INC | 6.9% |
|
VERTEX PHARMACEUTICALS INC | 6.1% |
|
REGENERON PHARMACEUTICALS | 5.3% |
|
IQVIA HOLDINGS INC | 3.7% |
 |
ARGENX SE ADR | 3.1% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.7% |
|
WATERS CORP | 2.3% |
|
BIOGEN IDEC INC | 2.2% |
|
UNITED THERAPEUTICS CORP | 1.6% |
IBB Underweight Relative to GNOM
 |
ENI SPA-SPONSORED ADR | -7.7% |
|
VERACYTE INC | -4.8% |
|
QIAGEN NV | -4.2% |
|
AGILENT TECHNOLOGIES INC | -4.0% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.9% |
|
BEAM THERAPEUTICS, INC. | -3.4% |
|
NATERA INC | -3.4% |
|
CRISPR THERAPEUTICS AG | -3.3% |
|
BIO-TECHNE CORPORATION | -3.0% |
|
ULTRAGENYX PHARMACEUTICAL IN | -2.8% |